Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Mithoefer

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?Allison A Feduccia, Michael C Mithoefer
The New England Journal of Medicine|November 3, 2017
Post-Traumatic Stress DisorderMichael C Mithoefer, Lisa Jerome, Candice Monson
Medical Hypotheses|November 18, 2020
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSDTimothy D Brewerton, Adele Lafrance, Michael C Mithoefer
Psychopharmacology|November 21, 2017
Progress and promise for the MDMA drug development programAllison A Feduccia, Julie Holland, Michael C Mithoefer
The Lancet. Psychiatry|April 13, 2016
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMAMichael C Mithoefer, Charles S Grob, Timothy D Brewerton
Psychopharmacology|November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Psychopharmacology|August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Journal of Psychoactive Drugs|March 21, 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case ExampleAnne C Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?Allison A Feduccia, Michael C Mithoefer
The New England Journal of Medicine|November 3, 2017
Post-Traumatic Stress DisorderMichael C Mithoefer, Lisa Jerome, Candice Monson
Medical Hypotheses|November 18, 2020
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSDTimothy D Brewerton, Adele Lafrance, Michael C Mithoefer
Psychopharmacology|November 21, 2017
Progress and promise for the MDMA drug development programAllison A Feduccia, Julie Holland, Michael C Mithoefer
The Lancet. Psychiatry|April 13, 2016
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMAMichael C Mithoefer, Charles S Grob, Timothy D Brewerton
Psychopharmacology|November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Psychopharmacology|August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Journal of Psychoactive Drugs|March 21, 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case ExampleAnne C Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Pageof 3